fbpx Skip to main content

Member's Profile


12544 High Bluff Dr., Suite 340
San Diego,   California
United States
Contact Info
(310) 214-9301
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About JCR USA, Inc.
Biotech Company
JCR USA, Inc. (JCR USA) is a joint venture company of two Japanese companies both of which are publicly listed on the Tokyo Stock Exchange. One of which is JCR Pharmaceutical Co., Ltd. (JCR) who owns 65% of JCR USA. JCR focuses on developing therapeutic enzyme for rare diseases especially Lysosomal Storage Diseases (“LSDs”) utilizing its proprietary blood-brain barrier penetration technology known as “J-Brain Cargo” technology. JCR has a series of therapeutic enzymes for LSD that utilize J-Brain Cargo in their development program. JCR USA controls and manages the clinical development program of JCR’s investigative biologics products mainly within the U.S.
Related News
No related news posted by this Member